All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Nathan Bowers
Man With Fever and Productive Cough
close Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out Cancel The Skill Checkup series provides a quick, case-style interactive quiz highlighting key guidelines- and evidence-based information to inform clinical practice. A 19-year-old man in the United States presents with a 3-day history of fever and productive cough associated with retrosternal chest pain.
Tacrolimus “swish and spit” for complex aphthosis: Outcomes in 21 patients
To the Editor: Complex aphthosis (CA) is characterized by a nearly constant presence of ≥3 oral or oral and genital aphthae in the absence of Behçet's disease or inflammatory bowel disease. Systemic treatments such as dapsone, colchicine, and thalidomide can be effective but are associated with potential serious adverse effects. , Topical ointments can be difficult to apply and/or may provide inadequate relief.
Methotrexate for pityriasis lichenoides et varioliformis acuta (Mucha-Habermann disease) and pityriasis lichenoides chronica: A retrospective case series of 33 patients with an emphasis on outcomes
To the Editor: Pityriasis lichenoides et varioliformis acuta (PLEVA) and pityriasis lichenoides chronica (PLC) are rare papulosquamous disorders. 1 Jung F. Sibbald C. Bohdanowicz M. Ingram J.R. Piguet V. Systematic review of the efficacies and adverse effects of treatments for pityriasis lichenoides. Br J Dermatol. 2020; 183: 1026-1032 While PLEVA/PLC can relapse and remit, persistent cases may warrant therapy. 1 Jung F. Sibbald C. Bohdanowicz M. Ingram J.R. Piguet V.
Mycophenolate mofetil versus methotrexate for vulvar lichen planus: A 10-year retrospective cohort study demonstrates comparable efficacy and tolerability
To the Editor: Lichen planus affecting the vulva (LPV) can have severe implications on patients' quality of life. 1 Dunaway S. Tyler K. Kaffenberger J. Update on treatments for erosive vulvovaginal lichen planus. While up to 40% of LPV patients fail to improve with topical monotherapy, systemic treatment data for LPV are limited. 1 Dunaway S. Tyler K. Kaffenberger J. Update on treatments for erosive vulvovaginal lichen planus.
Methotrexate for generalized granuloma annulare: 60% response rate in a retrospective case series of 15 patients
Article Info Publication History Accepted: July 22, 2021 Received in revised form: July 19, 2021 Received: June 24, 2021 Publication stage In Press Journal Pre-Proof Footnotes Funding sources: None Reviewed and approved by Wake Forest University Health Sciences IRB00072393 Disclosures: Steven Feldman has received research, speaking and/or consulting support from a variety of companies including Galderma, GSK/Stiefel, Almirall, Leo Pharma, Boehringer Ingelheim, Mylan, Celgene, Pfizer, Valeant,...
Increased PD-L1 Tumor Expression Correlates with High Rate of Response to PD-1 Inhibitors in Patients with Unresectable, Recurrent, and Metastatic Cutaneous Squamous Cell Carcinoma | SKIN The Journal of Cutaneous Medicine
Main Article Content Nathan Bowers Department of Dermatology, Wake Forest University, Wake Forest, NC Mercedes Porosnicu Department of Internal Medicine, Section of Hematology & Oncology, Wake Forest University School of Medicine, Winston Salem, NC Keywords Squamous Cell Carcinoma, PD-L1, PD-1 Inhibitor Abstract Background: PD-1 inhibitors were approved for locally advanced and metastatic cutaneous squamous cell carcinoma (CSCC) in 2019 with ORR of 47% and CR of 4%.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Nathan
Contact Nathan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack